Literature DB >> 15997421

Genetic and environmental influences on bone mineral density in pre- and post-menopausal women.

Lillian B Brown1, Elizabeth A Streeten, Jay R Shapiro, Daniel McBride, Alan R Shuldiner, Patricia A Peyser, Braxton D Mitchell.   

Abstract

Genetic factors influencing acquisition of peak bone mass account for a substantial proportion of the variation in bone mineral density (BMD), although the extent to which genes also contribute to variation in bone loss is debatable. Few prospective studies of related individuals have been carried out to address this issue. To gain insights into the nature of the genetic factors contributing to variation in BMD, we studied 570 women from large Amish families. We evaluated and compared the genetic contributions to BMD in pre- and post-menopausal women, with the rationale that genetic variation in pre-menopausal women is due primarily to genetic determinants of peak bone mass, while genetic variation in post-menopausal women is due to the combined genetic effects of peak bone mass and bone loss. Bone mineral density was measured at one point in time at the hip and spine by dual energy X-ray absorptiometry (DXA). We used variance decomposition procedures to partition variation in BMD into genetic and environmental effects common to both groups and to pre- and post-menopausal women separately. Total variation in BMD was higher in post- compared to pre-menopausal women. Genes accounted for 58-88% of the total variation in BMD in pre-menopausal women compared to 37-54% of the total variation in post-menopausal women. In absolute terms, however, the genetic variance was approximately similar between the two groups because the environmental variance was 3 1/2- to 4-fold larger in the post-menopausal group. The genetic correlation in total hip BMD was 0.81 between pre- and post-menopausal women and differed significantly from one, consistent with the presence of at least some non-overlapping genetic effects in the two groups for BMD at this site. Overall, these analyses suggest that many, but not all, of the genetic factors influencing variation in BMD are common to both pre- and post-menopausal women.

Entities:  

Mesh:

Year:  2005        PMID: 15997421      PMCID: PMC4049290          DOI: 10.1007/s00198-005-1948-7

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  30 in total

Review 1.  Genetics of osteoporosis.

Authors:  J A Eisman
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  Towards a complete North American Anabaptist Genealogy II: analysis of inbreeding.

Authors:  R Agarwala; A A Schäffer; J F Tomlin
Journal:  Hum Biol       Date:  2001-08       Impact factor: 0.553

Review 3.  The relative contribution of diet and genotype to bone development.

Authors:  A Prentice
Journal:  Proc Nutr Soc       Date:  2001-02       Impact factor: 6.297

4.  Bone mineral, serum calcium, and dietary intakes of mother/daughter pairs.

Authors:  J Lutz
Journal:  Am J Clin Nutr       Date:  1986-07       Impact factor: 7.045

5.  Leptin's sexual dimorphism results from genotype by sex interactions mediated by testosterone.

Authors:  Lisa J Martin; Michael C Mahaney; Laura Almasy; Jean W MacCluer; John Blangero; Cashell E Jaquish; Anthony G Comuzzie
Journal:  Obes Res       Date:  2002-01

Review 6.  Epidemiology and outcomes of osteoporotic fractures.

Authors:  Steven R Cummings; L Joseph Melton
Journal:  Lancet       Date:  2002-05-18       Impact factor: 79.321

7.  Reduced incidence of hip fracture in the Old Order Amish.

Authors:  Elizabeth A Streeten; Daniel J McBride; Amy L Lodge; Toni I Pollin; David G Stinchcomb; Richa Agarwala; Alejandro A Schäffer; Jay R Shapiro; Alan R Shuldiner; Braxton D Mitchell
Journal:  J Bone Miner Res       Date:  2003-12-16       Impact factor: 6.741

8.  Assessment of sex-specific genetic and environmental effects on bone mineral density.

Authors:  Lillian B Brown; Elizabeth A Streeten; Alan R Shuldiner; Laura A Almasy; Patricia A Peyser; Braxton D Mitchell
Journal:  Genet Epidemiol       Date:  2004-09       Impact factor: 2.135

9.  Genetic and environmental determinants of bone mineral density in Mexican Americans: results from the San Antonio Family Osteoporosis Study.

Authors:  Braxton D Mitchell; Candace M Kammerer; Jennifer L Schneider; Reina Perez; Richard L Bauer
Journal:  Bone       Date:  2003-11       Impact factor: 4.398

Review 10.  Bone loss. Epidemiology of bone loss.

Authors:  D J Hunter; P N Sambrook
Journal:  Arthritis Res       Date:  2000-08-03
View more
  29 in total

1.  A common variant in fibroblast growth factor binding protein 1 (FGFBP1) is associated with bone mineral density and influences gene expression in vitro.

Authors:  Nicole Hoppman; John C McLenithan; Daniel J McBride; Haiqing Shen; Jan Bruder; Richard L Bauer; John R Shaffer; Jie Liu; Elizabeth A Streeten; Alan R Shuldiner; Candace M Kammerer; Braxton D Mitchell
Journal:  Bone       Date:  2010-05-05       Impact factor: 4.398

2.  Cross-sectional versus longitudinal associations of lean and fat mass with pQCT bone outcomes in children.

Authors:  Howard E Wey; Teresa L Binkley; Tianna M Beare; Christine L Wey; Bonny L Specker
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

3.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis: executive summary of recommendations.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

4.  Polymorphisms in Wnt signaling pathway genes are associated with peak bone mineral density, lean mass, and fat mass in Chinese male nuclear families.

Authors:  Y Zheng; C Wang; H Zhang; C Shao; L-H Gao; S-S Li; W-J Yu; J-W He; W-Z Fu; Y-Q Hu; M Li; Y-J Liu; Z-L Zhang
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

5.  No association between polymorphisms of peroxisome [corrected] proliferator-activated receptor-gamma gene and peak bone mineral density variation in Chinese nuclear families.

Authors:  H Yue; J-W He; H Zhang; W-W Hu; Y-Q Hu; M Li; Y-J Liu; S-H Wu; Z-L Zhang
Journal:  Osteoporos Int       Date:  2009-07-31       Impact factor: 4.507

6.  Comparison of whole genome linkage scans in premenopausal and postmenopausal women: no bone-loss-specific QTLs were implicated.

Authors:  H Yan; Y-J Liu; Q Zhou; P Xiao; R R Recker; H-W Deng
Journal:  Osteoporos Int       Date:  2008-09-03       Impact factor: 4.507

Review 7.  The genetics of bone loss: challenges and prospects.

Authors:  Braxton D Mitchell; Laura M Yerges-Armstrong
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

8.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

9.  Quantitative trait loci for bone mineral density and femoral morphology in an advanced intercross population of mice.

Authors:  Larry J Leamy; Scott A Kelly; Kunjie Hua; Charles R Farber; Daniel Pomp
Journal:  Bone       Date:  2013-02-26       Impact factor: 4.398

10.  Haplotypes of intron 4 of the estrogen receptor alpha gene and hip fractures: a replication study in Caucasians.

Authors:  Javier Velasco; José L Hernández; José L Pérez-Castrillón; María T Zarrabeitia; María A Alonso; Jesús González-Macías; José A Riancho
Journal:  BMC Med Genet       Date:  2010-01-28       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.